To Control or Be Controlled: Navigating the Abuse Potential Evaluation of CNS-Active Drugs for EU and US Submissions
The first complimentary webinar in the series, "Virtues and Vices of Novel CNS-Active Drugs in Development," hosted by Altasciences and Sygnature Discovery. Register today!
Event End Date
Event Start Date